Skip to main content
Erschienen in: World Journal of Surgery 7/2008

01.07.2008

Treatment and Prevention of Recurrence of Multinodular Goiter: An Evidence-based Review of the Literature

verfasst von: Jacob Moalem, Insoo Suh, Quan-Yang Duh

Erschienen in: World Journal of Surgery | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Reportedly, 10−15% of patients with goiters ultimately require operative intervention, and recurrences of multinodular goiter (MNG) account for up to 12% of all thyroid operations.

Methods

We performed an evidence-based review of articles published in the English language between January 1987 and October 2007 relevant to the subject.

Results

Medical treatment with T4 appears to be associated with a greater proportion of patients whose nodules decreased in size by more than 50% (22% vs. 10%; range = 14–39% vs. 0–20%). Recurrence rates of benign nodular goiter after total thyroidectomy were essentially nonexistent (range = 0–0.3%) compared with those after subtotal thyroidectomy (range = 2.5–42%) and more limited resections (range = 8–34%). There was no difference between total and less-than-total thyroidectomy with respect to temporary recurrent laryngeal nerve (RLN) injury (1–10% vs. 0.9–6%, respectively) or permanent RLN palsy (0–1.4%). There was, however, a significantly higher rate of transient hypocalcemia after total thyroidectomy than less extensive operations (9–35% vs. 0–18%, respectively). In relation to redo surgery, permanent hypoparathyroidism appeared to be far more common in the redo group (0–22% vs. 0–4%) Moreover; the redo group had more frequent RLN injury, both temporary (0–22% vs. 0.5–18%) and permanent (0–13% vs. 0–4%). About half the studies examined conclude that postoperative TSH suppression is effective in reducing recurrences, while the other half state that it is not.

Conclusion

The definitive management and prevention of recurrence of benign nodular goiter is primarily surgical. Total thyroidectomy essentially eliminates the risk of recurrence without an accompanying increased risk of permanent hypoparathyroidism or RLN injury. Therefore, total thyroidectomy should be considered the procedure of choice for benign multinodular goiter whenever possible, especially considering that reoperations for goiter are significantly more morbid than any initial operation.
Literatur
1.
Zurück zum Zitat Gaitan E, Nelson NC, Poole GV (1991) Endemic goiter and endemic thyroid disorders. World J Surg 5:205–215CrossRef Gaitan E, Nelson NC, Poole GV (1991) Endemic goiter and endemic thyroid disorders. World J Surg 5:205–215CrossRef
2.
Zurück zum Zitat Muller PE, Jakoby R, Heinert G et al (2001) Surgery for recurrent goitre: its complications and their risk factors. Eur J Surg 167:816–821PubMedCrossRef Muller PE, Jakoby R, Heinert G et al (2001) Surgery for recurrent goitre: its complications and their risk factors. Eur J Surg 167:816–821PubMedCrossRef
3.
Zurück zum Zitat Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493CrossRef Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493CrossRef
4.
Zurück zum Zitat Brander A, Viikinkoski P, Nickels J et al (1991) Thyroid gland: US screening in a random adult population. Radiology 181:683–687PubMed Brander A, Viikinkoski P, Nickels J et al (1991) Thyroid gland: US screening in a random adult population. Radiology 181:683–687PubMed
5.
Zurück zum Zitat Mortensen JD, Woolner LB, Bennett WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280PubMedCrossRef Mortensen JD, Woolner LB, Bennett WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280PubMedCrossRef
6.
Zurück zum Zitat Matovinovic J (1983) Endemic goiter and cretinism at the dawn of the third millennium. Annu Rev Nutr 3:341–412PubMedCrossRef Matovinovic J (1983) Endemic goiter and cretinism at the dawn of the third millennium. Annu Rev Nutr 3:341–412PubMedCrossRef
7.
Zurück zum Zitat Torre G, Barreca A, Borgonovo G et al (2000) Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127:99–103PubMedCrossRef Torre G, Barreca A, Borgonovo G et al (2000) Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127:99–103PubMedCrossRef
8.
Zurück zum Zitat Kraimps JL, Marechaud R, Gineste D et al (1993) Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 176:319–322PubMed Kraimps JL, Marechaud R, Gineste D et al (1993) Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 176:319–322PubMed
9.
Zurück zum Zitat Seiler CA, Glaser C, Wagner HE (1996) Thyroid gland surgery in an endemic region. World J Surg 20:593–596; discussion 596–597PubMedCrossRef Seiler CA, Glaser C, Wagner HE (1996) Thyroid gland surgery in an endemic region. World J Surg 20:593–596; discussion 596–597PubMedCrossRef
10.
Zurück zum Zitat Miccoli P, Antonelli A, Iacconi P et al (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097–1101; discussion 1101–1092PubMed Miccoli P, Antonelli A, Iacconi P et al (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097–1101; discussion 1101–1092PubMed
11.
Zurück zum Zitat Bifulco M, Cavallo P (2007) Thyroidology in the medieval medical school of Salerno. Thyroid 17:39–40PubMedCrossRef Bifulco M, Cavallo P (2007) Thyroidology in the medieval medical school of Salerno. Thyroid 17:39–40PubMedCrossRef
12.
Zurück zum Zitat American Association of Clinical Endocrinologists (2004) Protocol for standardized production of clinical practice guidelines. Endocr Pract 10:353–361 American Association of Clinical Endocrinologists (2004) Protocol for standardized production of clinical practice guidelines. Endocr Pract 10:353–361
13.
Zurück zum Zitat Castro MR, Caraballo PJ, Morris JC (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154–4159PubMedCrossRef Castro MR, Caraballo PJ, Morris JC (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154–4159PubMedCrossRef
14.
Zurück zum Zitat Sdano MT, Falciglia M, Welge JA et al (2005) Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 133:391–396PubMedCrossRef Sdano MT, Falciglia M, Welge JA et al (2005) Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 133:391–396PubMedCrossRef
15.
Zurück zum Zitat Koc M, Ersoz HO, Akpinar I et al (2002) Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628CrossRef Koc M, Ersoz HO, Akpinar I et al (2002) Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628CrossRef
16.
Zurück zum Zitat Wemeau JL, Caron P, Schvartz C et al (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928–4934PubMedCrossRef Wemeau JL, Caron P, Schvartz C et al (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928–4934PubMedCrossRef
17.
Zurück zum Zitat Pappalardo G, Guadalaxara A, Frattaroli FM et al (1998) Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 164:501–506PubMedCrossRef Pappalardo G, Guadalaxara A, Frattaroli FM et al (1998) Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 164:501–506PubMedCrossRef
18.
Zurück zum Zitat Bellantone R, Lombardi CP, Boscherini M et al (2004) Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis. Surgery 136:1247–1251PubMedCrossRef Bellantone R, Lombardi CP, Boscherini M et al (2004) Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis. Surgery 136:1247–1251PubMedCrossRef
19.
Zurück zum Zitat Gibelin H, Sierra M, Mothes D et al (2004) Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients. World J Surg 28:1079–1082PubMedCrossRef Gibelin H, Sierra M, Mothes D et al (2004) Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients. World J Surg 28:1079–1082PubMedCrossRef
20.
Zurück zum Zitat Colak T, Akca T, Kanik A et al (2004) Total versus subtotal thyroidectomy for the management of benign multinodular goiter in an endemic region. ANZ J Surg 74:974–978PubMedCrossRef Colak T, Akca T, Kanik A et al (2004) Total versus subtotal thyroidectomy for the management of benign multinodular goiter in an endemic region. ANZ J Surg 74:974–978PubMedCrossRef
21.
Zurück zum Zitat Erbil Y, Barbaros U, Salmaslioglu A et al (2006) The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter. Langenbecks Arch Surg 391:567–573PubMedCrossRef Erbil Y, Barbaros U, Salmaslioglu A et al (2006) The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter. Langenbecks Arch Surg 391:567–573PubMedCrossRef
22.
Zurück zum Zitat Friguglietti CU, Lin CS, Kulcsar MA (2003) Total thyroidectomy for benign thyroid disease. Laryngoscope 113:1820–1826PubMedCrossRef Friguglietti CU, Lin CS, Kulcsar MA (2003) Total thyroidectomy for benign thyroid disease. Laryngoscope 113:1820–1826PubMedCrossRef
23.
Zurück zum Zitat Liu Q, Djuricin G, Prinz RA (1998) Total thyroidectomy for benign thyroid disease. Surgery 123:2–7PubMed Liu Q, Djuricin G, Prinz RA (1998) Total thyroidectomy for benign thyroid disease. Surgery 123:2–7PubMed
24.
Zurück zum Zitat Marchesi M, Biffoni M, Faloci C et al (2002) High rate of recurrence after lobectomy for solitary thyroid nodule. Eur J Surg 168:397–400PubMedCrossRef Marchesi M, Biffoni M, Faloci C et al (2002) High rate of recurrence after lobectomy for solitary thyroid nodule. Eur J Surg 168:397–400PubMedCrossRef
25.
Zurück zum Zitat Snook KL, Stalberg PL, Sidhu SB et al (2007) Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 31:593–598; discussion 599–600PubMedCrossRef Snook KL, Stalberg PL, Sidhu SB et al (2007) Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 31:593–598; discussion 599–600PubMedCrossRef
26.
Zurück zum Zitat Sosa JA, Bowman HM, Tielsch JM et al (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330PubMedCrossRef Sosa JA, Bowman HM, Tielsch JM et al (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330PubMedCrossRef
27.
Zurück zum Zitat Thomusch O, Machens A, Sekulla C et al (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335–1341PubMedCrossRef Thomusch O, Machens A, Sekulla C et al (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335–1341PubMedCrossRef
28.
Zurück zum Zitat Feldkamp J, Seppel T, Becker A et al (1997) Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21:10–14PubMedCrossRef Feldkamp J, Seppel T, Becker A et al (1997) Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21:10–14PubMedCrossRef
29.
Zurück zum Zitat Hegedus L, Nygaard B, Hansen JM (1999) Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84:756–760PubMedCrossRef Hegedus L, Nygaard B, Hansen JM (1999) Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84:756–760PubMedCrossRef
30.
Zurück zum Zitat Banchuin C, Panpimarnmas S (1997) Effect of post-operative thyroid hormone therapy on the recurrence of benign thyroid nodules. A study in Thai patients. J Med Assoc Thai 80:715–719PubMed Banchuin C, Panpimarnmas S (1997) Effect of post-operative thyroid hormone therapy on the recurrence of benign thyroid nodules. A study in Thai patients. J Med Assoc Thai 80:715–719PubMed
31.
Zurück zum Zitat Geerdsen JP, Frolund L (1984) Recurrence of nontoxic goitre with and without postoperative thyroxine medication. Clin Endocrinol (Oxf) 21:529–533CrossRef Geerdsen JP, Frolund L (1984) Recurrence of nontoxic goitre with and without postoperative thyroxine medication. Clin Endocrinol (Oxf) 21:529–533CrossRef
32.
Zurück zum Zitat Berghout A, Wiersinga WM, Drexhage HA et al (1989) The long-term outcome of thyroidectomy for sporadic non-toxic goitre. Clin Endocrinol (Oxf) 31:193–199CrossRef Berghout A, Wiersinga WM, Drexhage HA et al (1989) The long-term outcome of thyroidectomy for sporadic non-toxic goitre. Clin Endocrinol (Oxf) 31:193–199CrossRef
33.
Zurück zum Zitat Bistrup C, Nielsen JD, Gregersen G et al (1994) Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 40:323–327CrossRef Bistrup C, Nielsen JD, Gregersen G et al (1994) Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 40:323–327CrossRef
34.
Zurück zum Zitat Persson CP, Johansson H, Westermark K et al (1982) Nodular goiter—is thyroxine medication of any value? World J Surg 6:391–396PubMedCrossRef Persson CP, Johansson H, Westermark K et al (1982) Nodular goiter—is thyroxine medication of any value? World J Surg 6:391–396PubMedCrossRef
35.
Zurück zum Zitat Anderson PE, Hurley PR, Rosswick P (1990) Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 171:309–314PubMed Anderson PE, Hurley PR, Rosswick P (1990) Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 171:309–314PubMed
36.
Zurück zum Zitat Ibis E, Erbay G, Aras G et al (1991) Postoperative goitre recurrence rate in Turkey. Acta Endocrinol (Copenh) 125:33–37 Ibis E, Erbay G, Aras G et al (1991) Postoperative goitre recurrence rate in Turkey. Acta Endocrinol (Copenh) 125:33–37
37.
Zurück zum Zitat Subbiah S, Collins BJ, Schneider AB (2007) Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid 17:41–47PubMedCrossRef Subbiah S, Collins BJ, Schneider AB (2007) Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid 17:41–47PubMedCrossRef
38.
Zurück zum Zitat Wadstrom C, Zedenius J, Guinea A et al (1999) Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy? Aust N Z J Surg 69:34–36PubMedCrossRef Wadstrom C, Zedenius J, Guinea A et al (1999) Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy? Aust N Z J Surg 69:34–36PubMedCrossRef
39.
Zurück zum Zitat Roher HD, Goretzki PE (1987) Management of goiter and thyroid nodules in an area of endemic goiter. Surg Clin North Am 67:233–249PubMed Roher HD, Goretzki PE (1987) Management of goiter and thyroid nodules in an area of endemic goiter. Surg Clin North Am 67:233–249PubMed
40.
Zurück zum Zitat Bennedbaek FN, Hegedus L (2000) Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 85:2493–2498PubMedCrossRef Bennedbaek FN, Hegedus L (2000) Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 85:2493–2498PubMedCrossRef
41.
Zurück zum Zitat Bennedbaek FN, Perrild H, Hegedus L (1999) Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 50:357–363CrossRef Bennedbaek FN, Perrild H, Hegedus L (1999) Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 50:357–363CrossRef
42.
Zurück zum Zitat Astwood EB, Cassidy CE, Aurbach GD (1960) Treatment of goiter and thyroid nodules with thyroid. JAMA 174:459–464PubMed Astwood EB, Cassidy CE, Aurbach GD (1960) Treatment of goiter and thyroid nodules with thyroid. JAMA 174:459–464PubMed
43.
Zurück zum Zitat Schneeberg NG, Stahl TJ, Maldia G et al (1962) Regression of goiter by whole thyroid or triiodothyronine. Metabolism 11:1054–1060PubMed Schneeberg NG, Stahl TJ, Maldia G et al (1962) Regression of goiter by whole thyroid or triiodothyronine. Metabolism 11:1054–1060PubMed
44.
Zurück zum Zitat Hansen JM, Kampmann J, Madsen SN et al (1979) L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf) 10:1–6CrossRef Hansen JM, Kampmann J, Madsen SN et al (1979) L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf) 10:1–6CrossRef
45.
Zurück zum Zitat Perrild H, Hansen JM, Hegedus L et al (1982) Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh) 100:382–387 Perrild H, Hansen JM, Hegedus L et al (1982) Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh) 100:382–387
46.
Zurück zum Zitat La Rosa GL, Lupo L, Giuffrida D et al (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8PubMed La Rosa GL, Lupo L, Giuffrida D et al (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8PubMed
47.
Zurück zum Zitat Gharib H, James EM, Charboneau JW et al (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70–75PubMedCrossRef Gharib H, James EM, Charboneau JW et al (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70–75PubMedCrossRef
48.
Zurück zum Zitat Reverter JL, Lucas A, Salinas I et al (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28CrossRef Reverter JL, Lucas A, Salinas I et al (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28CrossRef
49.
50.
Zurück zum Zitat Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350–356PubMed Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350–356PubMed
51.
Zurück zum Zitat Sawin CT, Geller A, Wolf PA et al (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252PubMedCrossRef Sawin CT, Geller A, Wolf PA et al (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252PubMedCrossRef
52.
Zurück zum Zitat Biondi B, Fazio S, Palmieri EA et al (1999) [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function.]. Cardiologia 44:443–449PubMed Biondi B, Fazio S, Palmieri EA et al (1999) [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function.]. Cardiologia 44:443–449PubMed
53.
Zurück zum Zitat Bauer DC, Ettinger B, Nevitt MC et al (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568PubMed Bauer DC, Ettinger B, Nevitt MC et al (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568PubMed
54.
Zurück zum Zitat Harrer P, Broecker M, Zint A et al (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMed Harrer P, Broecker M, Zint A et al (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMed
55.
Zurück zum Zitat Harrer P, Brocker M, Zint A et al (1998) The clonality of nodules in recurrent goiters at second surgery. Langenbecks Arch Surg 383:453–455PubMedCrossRef Harrer P, Brocker M, Zint A et al (1998) The clonality of nodules in recurrent goiters at second surgery. Langenbecks Arch Surg 383:453–455PubMedCrossRef
56.
Zurück zum Zitat Goretzki P, Roeher HD, Horeyseck G (1981) Prophylaxis of recurrent goiter by high-dose L-thyroxine. World J Surg 5:855–857PubMedCrossRef Goretzki P, Roeher HD, Horeyseck G (1981) Prophylaxis of recurrent goiter by high-dose L-thyroxine. World J Surg 5:855–857PubMedCrossRef
57.
Zurück zum Zitat Hegedus L, Hansen JM, Veiergang D et al (1987) Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size? Br Med J (Clin Res Ed) 294:801–803CrossRef Hegedus L, Hansen JM, Veiergang D et al (1987) Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size? Br Med J (Clin Res Ed) 294:801–803CrossRef
58.
Zurück zum Zitat Carella C, Mazziotti G, Rotondi M et al (2002) Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin Endocrinol (Oxf) 57:507–513CrossRef Carella C, Mazziotti G, Rotondi M et al (2002) Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin Endocrinol (Oxf) 57:507–513CrossRef
59.
Zurück zum Zitat Guberti A, Sianesi M, Del Rio P et al (2002) Thyroid function and goiter recurrence after thyroid lobectomy in elderly subjects. J Endocrinol Invest 25:71–72PubMed Guberti A, Sianesi M, Del Rio P et al (2002) Thyroid function and goiter recurrence after thyroid lobectomy in elderly subjects. J Endocrinol Invest 25:71–72PubMed
60.
Zurück zum Zitat Erbil Y, Bozbora A, Yanik BT et al (2007) Predictive factors for recurrent non-toxic goitre in an endemic region. J Laryngol Otol 121:231–236PubMedCrossRef Erbil Y, Bozbora A, Yanik BT et al (2007) Predictive factors for recurrent non-toxic goitre in an endemic region. J Laryngol Otol 121:231–236PubMedCrossRef
61.
Zurück zum Zitat Lange MJ, Piercy JE (1957) Recurrent goitre. Lancet 272:177–181PubMed Lange MJ, Piercy JE (1957) Recurrent goitre. Lancet 272:177–181PubMed
62.
Zurück zum Zitat Makeieff M, Rubinstein P, Youssef B et al (1998) [Repeat surgery for thyroid nodules (excluding cancer and hyperthyroidism).]. Ann Chir 52:970–977PubMed Makeieff M, Rubinstein P, Youssef B et al (1998) [Repeat surgery for thyroid nodules (excluding cancer and hyperthyroidism).]. Ann Chir 52:970–977PubMed
63.
Zurück zum Zitat Farrag TY, Samlan RA, Lin FR et al (2006) The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 116:235–238PubMedCrossRef Farrag TY, Samlan RA, Lin FR et al (2006) The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 116:235–238PubMedCrossRef
64.
Zurück zum Zitat Ardito G, Revelli L, D’Alatri L et al (2004) Revisited anatomy of the recurrent laryngeal nerves. Am J Surg 187:249–253PubMedCrossRef Ardito G, Revelli L, D’Alatri L et al (2004) Revisited anatomy of the recurrent laryngeal nerves. Am J Surg 187:249–253PubMedCrossRef
65.
Zurück zum Zitat Steinberg JL, Khane GJ, Fernandes CM et al (1986) Anatomy of the recurrent laryngeal nerve: a redescription. J Laryngol Otol 100:919–927PubMedCrossRef Steinberg JL, Khane GJ, Fernandes CM et al (1986) Anatomy of the recurrent laryngeal nerve: a redescription. J Laryngol Otol 100:919–927PubMedCrossRef
66.
Zurück zum Zitat Dralle H, Sekulla C, Haerting J et al (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310–1322PubMedCrossRef Dralle H, Sekulla C, Haerting J et al (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310–1322PubMedCrossRef
67.
Zurück zum Zitat Cohen-Kerem R, Schachter P, Sheinfeld M et al (2000) Multinodular goiter: the surgical procedure of choice. Otolaryngol Head Neck Surg 122:848–850PubMedCrossRef Cohen-Kerem R, Schachter P, Sheinfeld M et al (2000) Multinodular goiter: the surgical procedure of choice. Otolaryngol Head Neck Surg 122:848–850PubMedCrossRef
68.
Zurück zum Zitat Piraneo S, Vitri P, Galimberti A et al (1994) Recurrence of goitre after operation in euthyroid patients. Eur J Surg 160:351–356PubMed Piraneo S, Vitri P, Galimberti A et al (1994) Recurrence of goitre after operation in euthyroid patients. Eur J Surg 160:351–356PubMed
69.
Zurück zum Zitat Reeve TS, Delbridge L, Cohen A et al (1987) Total thyroidectomy. The preferred option for multinodular goiter. Ann Surg 206:782–786PubMedCrossRef Reeve TS, Delbridge L, Cohen A et al (1987) Total thyroidectomy. The preferred option for multinodular goiter. Ann Surg 206:782–786PubMedCrossRef
70.
Zurück zum Zitat Rios A, Rodriguez JM, Canteras M et al (2005) Surgical management of multinodular goiter with compression symptoms. Arch Surg 140:49–53PubMedCrossRef Rios A, Rodriguez JM, Canteras M et al (2005) Surgical management of multinodular goiter with compression symptoms. Arch Surg 140:49–53PubMedCrossRef
71.
Zurück zum Zitat Rios A, Rodriguez JM, Balsalobre MD et al (2005) Results of surgery for toxic multinodular goiter. Surg Today 35:901–906PubMedCrossRef Rios A, Rodriguez JM, Balsalobre MD et al (2005) Results of surgery for toxic multinodular goiter. Surg Today 35:901–906PubMedCrossRef
72.
Zurück zum Zitat Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725–727PubMed Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725–727PubMed
73.
Zurück zum Zitat Delbridge L, Guinea AI, Reeve TS (1999) Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 134:1389–1393PubMedCrossRef Delbridge L, Guinea AI, Reeve TS (1999) Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 134:1389–1393PubMedCrossRef
74.
Zurück zum Zitat Menegaux F, Turpin G, Dahman M et al (1999) Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery 126:479–483PubMed Menegaux F, Turpin G, Dahman M et al (1999) Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery 126:479–483PubMed
75.
Zurück zum Zitat Lang BH, Lo CY (2005) Total thyroidectomy for multinodular goiter in the elderly. Am J Surg 190:418–423PubMedCrossRef Lang BH, Lo CY (2005) Total thyroidectomy for multinodular goiter in the elderly. Am J Surg 190:418–423PubMedCrossRef
76.
Zurück zum Zitat Zambudio AR, Rodriguez J, Riquelme J et al (2004) Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240:18–25PubMedCrossRef Zambudio AR, Rodriguez J, Riquelme J et al (2004) Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240:18–25PubMedCrossRef
78.
Zurück zum Zitat Berglund J, Bondesson L, Christensen SB et al (1990) Indications for thyroxine therapy after surgery for nontoxic benign goitre. Acta Chir Scand 156:433–438PubMed Berglund J, Bondesson L, Christensen SB et al (1990) Indications for thyroxine therapy after surgery for nontoxic benign goitre. Acta Chir Scand 156:433–438PubMed
79.
Zurück zum Zitat Karanikolic A, Pesic M, Djordevic N et al (2007) Optimal surgical treatment for bilateral multinodular goitre. Surg Prac 11:12–16CrossRef Karanikolic A, Pesic M, Djordevic N et al (2007) Optimal surgical treatment for bilateral multinodular goitre. Surg Prac 11:12–16CrossRef
Metadaten
Titel
Treatment and Prevention of Recurrence of Multinodular Goiter: An Evidence-based Review of the Literature
verfasst von
Jacob Moalem
Insoo Suh
Quan-Yang Duh
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9477-0

Weitere Artikel der Ausgabe 7/2008

World Journal of Surgery 7/2008 Zur Ausgabe

Letter

Reply

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.